NO971789D0 - Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler - Google Patents

Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler

Info

Publication number
NO971789D0
NO971789D0 NO971789A NO971789A NO971789D0 NO 971789 D0 NO971789 D0 NO 971789D0 NO 971789 A NO971789 A NO 971789A NO 971789 A NO971789 A NO 971789A NO 971789 D0 NO971789 D0 NO 971789D0
Authority
NO
Norway
Prior art keywords
tert
inflammatory agents
heterocyclic moiety
butylphenol compounds
butylphenol
Prior art date
Application number
NO971789A
Other languages
English (en)
Other versions
NO971789L (no
Inventor
Michael Wiard Scherz
Stanislaw Pikul
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO971789D0 publication Critical patent/NO971789D0/no
Publication of NO971789L publication Critical patent/NO971789L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO971789A 1994-10-20 1997-04-18 Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler NO971789L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/326,619 US5510361A (en) 1994-10-20 1994-10-20 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
PCT/US1995/012878 WO1996012710A1 (en) 1994-10-20 1995-10-18 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO971789D0 true NO971789D0 (no) 1997-04-18
NO971789L NO971789L (no) 1997-06-19

Family

ID=23272988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971789A NO971789L (no) 1994-10-20 1997-04-18 Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler

Country Status (8)

Country Link
US (1) US5510361A (no)
EP (1) EP0787130A1 (no)
JP (1) JPH10507754A (no)
KR (1) KR100226509B1 (no)
AU (1) AU705645B2 (no)
FI (1) FI971674A0 (no)
NO (1) NO971789L (no)
WO (1) WO1996012710A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4408084A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP3588734B2 (ja) * 1996-07-26 2004-11-17 コニカミノルタホールディングス株式会社 電子写真感光体
US5985930A (en) * 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6815555B2 (en) 2001-09-26 2004-11-09 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
US6555563B1 (en) 2001-11-16 2003-04-29 Medinox, Inc. Heteroaryl substituted amidinyl and imidazolyl compounds and methods employing same for the treatment of inflammation
WO2004064781A2 (en) * 2003-01-14 2004-08-05 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
US20050003024A1 (en) * 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
US20050255059A1 (en) * 2004-05-10 2005-11-17 Oblong John E Personal care compositions and methods regulating mammalian hair growth
US20050255060A1 (en) * 2004-05-10 2005-11-17 Oblong John E Personal care compositions and methods regulating mammalian hair growth
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US20070203240A1 (en) * 2006-02-27 2007-08-30 The Procter & Gamble Company Personal care compositions and methods for regulating mammalian hair growth
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
RU2661156C2 (ru) 2013-03-14 2018-07-12 Дарт Нейросайенс (Кайман) Лтд. Замещенные нафтиридиновые и хинолиновые соединения как ингибиторы мао
US9550754B2 (en) 2014-09-11 2017-01-24 AbbVie Deutschland GmbH & Co. KG 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR61620B (en) * 1976-10-14 1978-12-04 Byk Gulden Lomberg Chem Fab Preparation process of pyrazol-1-yl-phenyloxic acids
US4535165A (en) * 1981-11-23 1985-08-13 Riker Laboratories, Inc. Substituted diazoles and thiazoles
JPS58148858A (ja) * 1982-02-26 1983-09-05 Yamanouchi Pharmaceut Co Ltd ３，５−ジ−ｔｅｒｔ−ブチル−４−ヒドロキシフエニル置換複素環化合物
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
JPH0615542B2 (ja) * 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US4724246A (en) * 1986-12-10 1988-02-09 Ciba-Geigy Corporation Substituted 1,3,4-oxathiazol-2-one stabilizers
DE3702756A1 (de) * 1987-01-30 1988-08-11 Hoechst Ag 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2- amino-6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
DE3702757A1 (de) * 1987-01-30 1988-08-11 Hoechst Ag Neue imidazo- und triazolo-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
JPH01180878A (ja) * 1988-01-11 1989-07-18 Yoshitomi Pharmaceut Ind Ltd 縮合ピラゾール化合物
US5155122A (en) * 1988-11-29 1992-10-13 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents
JPH02229169A (ja) * 1989-03-01 1990-09-11 Takeda Chem Ind Ltd ピラゾロン誘導体
DE3918979A1 (de) * 1989-06-10 1990-12-13 Basf Ag Verfahren zur herstellung von pyrazol und dessen derivaten
DE4408084A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO971789L (no) 1997-06-19
US5510361A (en) 1996-04-23
FI971674A (fi) 1997-04-18
EP0787130A1 (en) 1997-08-06
AU705645B2 (en) 1999-05-27
JPH10507754A (ja) 1998-07-28
KR100226509B1 (ko) 1999-10-15
WO1996012710A1 (en) 1996-05-02
AU3859895A (en) 1996-05-15
FI971674A0 (fi) 1997-04-18
KR970707108A (ko) 1997-12-01
MX9702941A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
NO971789D0 (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
DK0946510T3 (da) Hidtil ukendte forbindelser med analgetisk virkning
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
PT996622E (pt) Novos compostos heterociclicos espiroazabiciclicos
NO960393D0 (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
PT946511E (pt) Novos compostos com efeito analgesico
NO970800D0 (no) Spiroazabicykliske forbindelser som er nyttige i terapi
PT966430E (pt) Compostos anti-inflamatorios
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO20010331D0 (no) Ftalazinderivater som fosfodiesterase 4-inhibitorer
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
ID17561A (id) Komposisi untuk pemakaian luar
DK1086097T3 (da) Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler
FI960367A (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
FI940992A0 (fi) Cylindergrupp med enkelt viradrag i torkningspartiet av en pappersmaskin och torkningsparti i pappersmaskin som innehaoller dessa
FI972585A0 (fi) Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset
DE59509209D1 (de) Diphenyloxazolin-derivate
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
ATE182133T1 (de) Naphtochinonderivate
DE69515498T2 (de) Naphthyridinderivate
NO962535D0 (no) Di-tert-butylfenolforbindelser anvendbare som antiflammatoriske midler
SE9402122D0 (sv) Heterocyclic compounds